Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Researchers at GlaxoSmithKline disclose new EZH2 inhibitors

Dec. 5, 2011

Sentinel Oncology synthesizes novel Chk1 inhibitors

Dec. 5, 2011

Nerviano Medical Sciences presents preclinical findings on NMS-P948

Dec. 5, 2011

Researchers uncover mechanism of action of epigenetic modifier UVI-5008

Dec. 5, 2011

Celldex Therapeutics begins phase III trial of rindopepimut

Dec. 2, 2011

Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907

Dec. 2, 2011

Novel caspase-3 activators and apoptosis inducers reported in patent literature

Dec. 2, 2011

Novel PI3K and mTOR inhibitors patented by Spanish researchers

Dec. 2, 2011

Costimulatory fusion protein enhances activity of tumor vaccine in vivo

Dec. 2, 2011

First-in-human results presented on PRS-050 in patients with advanced solid malignancies

Dec. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...